Our study’s findings resonate with recent evidence from the IP1-PROSTAGRAM study, which (13) demonstrated a clear preference for MRI over PSA and ultrasound in prostate cancer screening (13). The gene discussed is KLK3; the disease is Familial prostate cancer.